NC
RGEN icon

nVerses Capital’s Repligen RGEN Stock Holding History

nVerses Capital’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-300
Closed -$44.6K – 695
2024
Q3 		$44.6K Buy
+300
New +$43K 0.02% 668

Other funds holding RGEN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

nVerses Capital's RGEN Position: Q4 2024 in Review

nVerses Capital sold out of Repligen (RGEN) in Q4 2024, closing a stake of 300 shares — an estimated $44.6K sold.

nVerses Capital first reported a position in RGEN in Q3 2024 and held it in 1 quarter. The position peaked at $44.6K in Q3 2024. 431 funds tracked by Wall St. Rank hold RGEN as of Q4 2024.

  • nVerses Capital reported no remaining Repligen position as of Q4 2024 after selling out during the quarter.
  • nVerses Capital sold 300 Repligen shares in Q4 2024, an estimated $44.6K.
  • nVerses Capital first reported a position in Repligen in Q3 2024 and held it in 1 quarter.
  • nVerses Capital's Repligen position peaked at $44.6K in Q3 2024.
  • 431 funds tracked by Wall St. Rank held Repligen as of Q4 2024.

Based on nVerses Capital's 13F filing for Q4 2024.